Dec 06, 2024
At present, there are no FDA-approved celiac disease therapies in the therapeutic segment. The only available treatment is a strict, lifelong gluten-free diet, which can be costly and challenging to follow. Many patients experience incomplete intestinal healing and persistent symptoms, often due to difficulties in ...
Read More...
Dec 02, 2024
Celiac disease is considered a serious autoimmune disease, which is estimated to affect 1 in 100 people worldwide. Moreover, 2.5 million Americans are undiagnosed and are at risk for long-term health complications. As per secondary, commonly known clinical types of celiac disease include Classical, Non-cla...
Read More...
Aug 14, 2020
The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving Celiac disease market size. Who would have thought that consumption of gluten can trigger an autoimmune disorder? Alth...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper